Uploaded June 2026 | Updated September 2026, 3 days ago
How do clinical guidelines move from research evidence to recommendations that influence diabetes care worldwide?
In this interview from the 61st EASD Annual Meeting, Vivienne Parry speaks with Dr Thomas Karagiannis and Dr Francesco Zaccardi about the rigorous methodology behind EASD guideline development.
They discuss why transparent processes and conflict-of-interest management are essential, how systematic reviews and meta-analyses underpin recommendations, and why patient perspectives are increasingly important in modern guideline development.
The conversation also explores the first EASD guideline on diabetes distress, future guidance on continuous glucose monitoring in type 2 diabetes and diabetes prevention, and the emerging role of artificial intelligence in evidence synthesis.
Subscribe for more interviews, research highlights and expert discussions from the EASD community.
How do clinical guidelines move from research evidence to recommendations that influence diabetes care worldwide?
In this interview from the 61st EASD Annual Meeting, Vivienne Parry speaks with Dr Thomas Karagiannis and Dr Francesco Zaccardi about the rigorous methodology behind EASD guideline development.
They discuss why transparent processes and conflict-of-interest management are essential, how systematic reviews and meta-analyses underpin recommendations, and why patient perspectives are increasingly important in modern guideline development.
The conversation also explores the first EASD guideline on diabetes distress, future guidance on continuous glucose monitoring in type 2 diabetes and diabetes prevention, and the emerging role of artificial intelligence in evidence synthesis.
Subscribe for more interviews, research highlights and expert discussions from the EASD community.
